SCHEMBL24255781

SCHEMBL24255781

CCOC(=O)/C(=C/c1c(NC(=O)OC(C)(C)C)cnn1C)CC#N

nearest known ligand 0.33

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ AR P10275 3/20 0.33
▸ KCNQ4 P56696 2/20 0.33
▸ KCNQ5 Q9NR82 2/20 0.33
▸ ALDH1A1 P00352 5/20 0.33
▸ GAA P10253 3/20 0.33
▸ L3MBTL1 Q9Y468 1/20 0.33
▸ MAPT P10636 4/20 0.32
▸ NPC1 O15118 2/20 0.32
▸ RAB9A P51151 2/20 0.32
▸ SMN1; SMN2 Q16637 2/20 0.32
▸ NPSR1 Q6W5P4 2/20 0.32
▸ LMNA P02545 1/20 0.32
▸ MEN1 O00255 2/20 0.31
▸ KMT2A Q03164 2/20 0.31
▸ USP2 O75604 1/20 0.31
▸ NLRP3 Q96P20 1/20 0.31
▸ GSK3B P49841 1/20 0.31
▸ DYRK1A Q13627 1/20 0.31
▸ MAPK14 Q16539 1/20 0.31
▸ ATM Q13315 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25408853 0.88 AR (0.35) ARGSK3BDYRK1AMAPK14TTK
SCHEMBL27399415 0.79 ALDH1A1 (0.37) KCNQ4KCNQ5ALDH1A1GAAL3MBTL1
SCHEMBL29260330 0.78 CYP17A1 (0.35) KCNQ4KCNQ5ALDH1A1GAAL3MBTL1
SCHEMBL23289646 0.77 LMNA (0.37) KCNQ4KCNQ5ALDH1A1GAAL3MBTL1
SCHEMBL6133253 0.73 MAPK14 (0.40) RAB9ALMNAGSK3BDYRK1AMAPK14
SCHEMBL26291956 0.72 DRD2 (0.34) ALDH1A1MAPTNPSR1LMNAMEN1
SCHEMBL23311454 0.70 DHODH (0.39) ALDH1A1GAAL3MBTL1MAPTNPC1
SCHEMBL6133365 0.69 BRD9 (0.35) ALDH1A1GAALMNAGSK3BDYRK1A
SCHEMBL6133366 0.69 BRD9 (0.35) ALDH1A1GAALMNAGSK3BDYRK1A
SCHEMBL26291990 0.69 NAMPT (0.35) ALDH1A1GAAL3MBTL1MAPTNPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230263903-A1 PYRAZOLOAZEPINE IMMUNOCONJUGATES, AND USES THEREOF BOLT BIOTHERAPEUTICS, INC. (US) 2023-08-24 — — US disclosed
CN-116234586-A Pyrazoloazepine immunoconjugates and uses thereof 博尔特生物治疗药物有限公司 2023-06-06 — — CN disclosed
WO-2022036101-A1 PYRAZOLOAZEPINE IMMUNOCONJUGATES, AND USES THEREOF BOLT BIOTHERAPEUTICS, INC. (US) 2022-02-17 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230263903-A1 PYRAZOLOAZEPINE IMMUNOCONJUGATES, AND USES THEREOF KCNJ5, IL5, CYP3A5 AR 2796/4885KCNQ4 133/4885KCNQ5 51/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback